insights_auto
Why is ALCOX up 4,75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
0,31 €
arrow_upward
+4,75%(+0,014) 1D
9 ოქტ, 17:35:31 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
26,44 მლნ.
Avg. vol.
170,04 ათ.
Volume
90,64 ათ.
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 მლნ.
No. of employees
10
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
26,44 მლნ.
Avg. vol.
170,04 ათ.
Volume
90,64 ათ.
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 მლნ.
No. of employees
10
News stories
From web sources and news partners
MarketBeat
·
16 წუთის წინ
LegalZoom.com, Inc. (NASDAQ:LZ) Stock Has Consensus Price Target of $7.30
Simply Wall Street
·
23 წუთის წინ
ASML (NasdaqGS:ASML) Stock Could Be Fully Valued As AI Demand Builds
MarketBeat
·
16 წუთის წინ
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Stock Rated "Moderate Buy" by Sell-Side Analysts
Yahoo Finance
·
8 საათის წინ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, პროვანსი-ალპები-ლაჟვარდოვანი ნაპირი, საფრანგეთი
Sector-
Websitenicox.com